Cellectar Biosciences Inc Share Price Today: Live Updates & Key Insights
Cellectar Biosciences Inc share price today is $2.4, up -2.43%. The stock opened at $2.45 against the previous close of $2.47, with an intraday high of $2.46 and low of $2.37.
Cellectar Biosciences Inc Share Price Chart
Cellectar Biosciences Inc
Cellectar Biosciences Inc Share Price Performance
Cellectar Biosciences Inc Institutional Holdings
Cellectar Biosciences Inc Market Status
Cellectar Biosciences Inc Fundamentals
Market Cap 19.74 M
PB Ratio 7.0198
PE Ratio 0.0
Enterprise Value 13.46 M
Total Assets 14.98 M
Volume 36061
Cellectar Biosciences Inc Company Financials
About Cellectar Biosciences Inc & investment objective
Company Information Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. It also develops CLR 121125, an iodine-125 Auger-emitting radioconjugate program; and CLR 225, an actinium-225 based radioconjugate program. The company has collaborative with Orano Med to develop alpha emitter lead-212 conjugated to phospholipid ether series; and LegoChem Bio. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.
Organisation Biotechnology
Employees 11
Industry Biotechnology
CEO Mr. James V. Caruso
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Cellectar Biosciences Inc FAQs
What is the share price of Cellectar Biosciences Inc today?
The current share price of Cellectar Biosciences Inc is $2.4.
Can I buy Cellectar Biosciences Inc shares in India?
Yes, Indian investors can buy Cellectar Biosciences Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Cellectar Biosciences Inc shares in India?
You can easily invest in Cellectar Biosciences Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Cellectar Biosciences Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Cellectar Biosciences Inc.
Can I buy fractional shares of Cellectar Biosciences Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Cellectar Biosciences Inc?
Cellectar Biosciences Inc has a market cap of $19.74 M.
In which sector does Cellectar Biosciences Inc belong?
Cellectar Biosciences Inc operates in the Biotechnology sector.
What documents are required to invest in Cellectar Biosciences Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Cellectar Biosciences Inc?
The PE ratio of Cellectar Biosciences Inc is N/A and the PB ratio is 7.02.